Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists. - Wikidata - awgldk - TriplyDB

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

http://www.wikidata.org/entity/Q37262697

about

Successful drug development despite adverse preclinical findings part 2: examples.System level changes in gene expression in maturing bladder mucosa.DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents.Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.Relationships between pulmonary micro-RNA and proteome profiles, systemic cytogenetic damage and lung tumors in cigarette smoke-exposed mice treated with chemopreventive agents.Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis.

P2860

Q35603965-1FDC264A-5320-4A29-A38F-CEF5FC959A66 Q36125243-737061E6-E49B-4C70-8C39-992F89D1B1EC Q36499766-8632E7FE-2DD7-498C-A660-2C834528B4D1 Q36505700-C0AF9E6B-00DB-43B0-84FE-983908C9DCFE Q37205860-42336112-F3B6-47DA-8835-62D7086E04B8 Q38061184-9DFF1241-7FAE-4212-94F3-86187BCC8271 Q45974480-CA057AE8-CEB7-47D4-A8F0-0FD69744B88D

P2860

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

http://www.wikidata.org/entity/Q37262697

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

@en

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

@nl

type

label

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

@en

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

@nl

prefLabel

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

@en

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

@nl

P1433

Q37262697-C149A7DA-C77F-4931-8674-A781A30FF506

P1476

Q37262697-AA2DE1EA-848F-41AC-966B-1C32C201AA44

P2093

Q37262697-149ED209-6298-4A33-A068-F2C7955B76C9

Q37262697-1F79157E-06CC-4EB9-B208-C62C43CDF48C

Q37262697-75961A30-8A7A-4279-88D2-A2C7D268CFC0

Q37262697-8C8426B2-8E23-4F88-AE04-8A740CCEE27F

Q37262697-AB38C9E9-8F55-45A8-AF6D-3E4A6080C16C

Q37262697-B8DF1C54-9A1E-4E5D-858C-B5844DAD1700

Q37262697-E1B7C7C9-8DD0-4DBE-A132-85BA5D405E5A

Q37262697-FFFAC7C8-0A7C-4E17-B4F5-346B57793F17

P2860

Q37262697-3A431A7D-1CA4-4394-A700-DF443F9D84AC

Q37262697-41AF31B6-3A83-4ED4-BACF-D42FFE793EE8

Q37262697-4ADAADE1-2DA7-4940-893B-96C52301554A

Q37262697-667F226B-1859-4CE4-81D3-7F25FE33D43E

Q37262697-7A0C1FA6-B10A-4E3A-9AAF-356B750D499B

Q37262697-CDEFF037-68E2-4CF2-8577-4B5FE506313F

Q37262697-FA306866-0CF8-4EB2-AF5C-B40E4606E4A0

P304

Q37262697-568420F2-8069-4431-BE4B-D8D60039ED19

P31

Q37262697-342D23B8-2E5B-47DF-B778-8A9457D90884

P356

Q37262697-10A424F3-CB37-46E5-A4C5-FDFBCBB4EA54

P407

Q37262697-6F6E6A65-10A1-4460-9860-2D9A5C8D0375

P433

Q37262697-C6AFDDF5-64B0-43E8-8592-8E9FFC1C0295

P478

Q37262697-B55E67EF-C9BF-43FE-9468-72800CD02E09

P577

Q37262697-CDF3B6A0-5A99-4CD8-B672-B3483DE66973

P5875

Q37262697-809ED4BA-B4FF-47B6-864E-0B467FE52F72

P698

Q37262697-D3A2DA9C-C8CA-440A-AE5A-2103EAAD95A8

P356

0192623308323624

P1433

Toxicologic Pathology

P1476

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.

@en

P2093

Daniel C Anderson

http://www.w3.org/2001/XMLSchema#string

Fletcher F Hahn

http://www.w3.org/2001/XMLSchema#string

Holly Kolenda-Roberts

http://www.w3.org/2001/XMLSchema#string

J Mark Cline

http://www.w3.org/2001/XMLSchema#string

Jerry F Hardisty

http://www.w3.org/2001/XMLSchema#string

Linda J Lowenstine

http://www.w3.org/2001/XMLSchema#string

Scott Brodie

http://www.w3.org/2001/XMLSchema#string

Subodh M Lele

http://www.w3.org/2001/XMLSchema#string

P2860

Thiazolidinediones.

PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.

Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists.

Cyr61 mediates the expression of VEGF, alphav-integrin, and alpha-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells.

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Cytoplasmic inclusions in urinary bladder epithelium of the rhesus monkey. A histochemical, light-and electron-microscopic study.

P304

769-776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0192623308323624

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23242129

http://www.w3.org/2001/XMLSchema#string

P698

18776159

http://www.w3.org/2001/XMLSchema#string